Frontotemporal Lobar Degeneration (FTLD) is a brain disorder that affects personality, behavior, and language. The ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) study aims to understand FTLD better. There are two parts to this study: a "longitudinal arm" and a "biofluid-focused arm." The longitudinal arm collects a lot of information about the participant's health each year, while the biofluid arm focuses on collecting samples like blood.
Participants can be from families with a history of FTLD or have the condition without any known family link. However, participants shouldn't have conditions like Alzheimer's or other serious illnesses that might confuse the results.
- **Study Length:** Ongoing yearly visits for the longitudinal arm.
- **Incentives:** Participation helps advance research but no mention of direct compensation.
- **Eligibility:** Must not have other major brain issues or diseases like Alzheimer's.
More details can be found on the ALLFTD website.
How understandable was the trial content above?
Hard to understand
Easy to understand